The best fit for the Pfizer data we have at hand is that significant fraud occurred in the recruitment process for the trial. Otherwise, we’re supposed to believe that a single site recruited as “few” as 4,501 patients and possibly as many as 4,501 + 1,275 = 5,776 in an extreme five-week burst right before…